• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

卡那霉素一种新氨基糖苷衍生物的体外评估，与妥布霉素和庆大霉素的比较。

In vitro evaluation of a new aminoglycoside derivative of kanamycin, a comparison with tobramycin and gentamycin.

作者信息

Ries K, Levison M E, Kaye D

出版信息

Antimicrob Agents Chemother. 1973 Apr;3(4):532-3. doi: 10.1128/AAC.3.4.532.

DOI:10.1128/AAC.3.4.532
PMID:4790607
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC444449/
Abstract

Against more than 90% of 200 bacterial strains tested in vitro, the inhibitory concentration of gentamicin and tobramycin was 3.1 mug/ml and that of BB-K 8, a new semisynthetic aminoglycoside derivative of kanamycin, was 6.3 mug/ml.

摘要

在体外对200种细菌菌株进行的测试中，庆大霉素和妥布霉素对90%以上的菌株的抑菌浓度为3.1微克/毫升，而卡那霉素的一种新型半合成氨基糖苷衍生物BB-K 8的抑菌浓度为6.3微克/毫升。

相似文献

1
In vitro evaluation of a new aminoglycoside derivative of kanamycin, a comparison with tobramycin and gentamycin.卡那霉素一种新氨基糖苷衍生物的体外评估，与妥布霉素和庆大霉素的比较。
Antimicrob Agents Chemother. 1973 Apr;3(4):532-3. doi: 10.1128/AAC.3.4.532.
2
Comparison of five aminocyclitol antibiotics in vitro against Enterobacteriaceae and Pseudomonas.五种氨基环醇类抗生素对肠杆菌科细菌和假单胞菌的体外比较。
Antimicrob Agents Chemother. 1973 Mar;3(3):338-42. doi: 10.1128/AAC.3.3.338.
3
Newer aminoglycosides--amikacin and tobramycin: an in-vitro comparison with kanamycin and gentamicin.新型氨基糖苷类药物——阿米卡星和妥布霉素：与卡那霉素和庆大霉素的体外比较。
Br Med J. 1974 Sep 28;3(5934):778-80. doi: 10.1136/bmj.3.5934.778.
4
Tobramycin: in vitro activity and comparison with kanamycin and gentamicin.妥布霉素：体外活性及与卡那霉素和庆大霉素的比较
Antimicrob Agents Chemother. 1972 Apr;1(4):340-2. doi: 10.1128/AAC.1.4.340.
5
Activity of BB-K8 (amikacin) against clinical isolates resistant to one or more aminoglycoside antibiotics.BB-K8（阿米卡星）对耐一种或多种氨基糖苷类抗生素的临床分离株的活性。
Antimicrob Agents Chemother. 1974 Feb;5(2):143-52. doi: 10.1128/AAC.5.2.143.
6
Comparison of the in vitro activities of BB-K8 and three other aminoglycosides against 215 strains of Pseudomonas and Enterobacteriaceae with variable sensitivity to kanamycin and gentamicin.BB-K8与其他三种氨基糖苷类药物对215株对卡那霉素和庆大霉素敏感性各异的假单胞菌属和肠杆菌科细菌的体外活性比较。
Chemotherapy. 1975;21(1):45-51. doi: 10.1159/000221843.
7
Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.铜绿假单胞菌和肠道革兰氏阴性杆菌的当前临床分离株对阿米卡星和其他氨基糖苷类抗生素的敏感性。
J Infect Dis. 1976 Nov;134 SUPPL:S394-90.
8
In vitro studies of BB-K8, a new aminoglycoside antibiotic.新型氨基糖苷类抗生素BB-K8的体外研究
Antimicrob Agents Chemother. 1973 Aug;4(2):186-92. doi: 10.1128/AAC.4.2.186.
9
In vitro comparison of four aminoglycoside antibiotics: sisomicin, gentamicin, tobramycin, and BB-K8.四种氨基糖苷类抗生素的体外比较：西索米星、庆大霉素、妥布霉素和BB-K8。
Antimicrob Agents Chemother. 1974 Jun;5(6):667-9. doi: 10.1128/AAC.5.6.667.
10
Comparative in vitro activity of three aminoglycosidic antibiotics: BB-K8, kanamycin, and gentamicin.三种氨基糖苷类抗生素BB-K8、卡那霉素和庆大霉素的体外活性比较
Antimicrob Agents Chemother. 1973 Aug;4(2):133-9. doi: 10.1128/AAC.4.2.133.

引用本文的文献

1
Combined activity of sulfamethoxazole, trimethoprim, and polymyxin B against gram-negative bacilli.磺胺甲恶唑、甲氧苄啶和多粘菌素B对革兰氏阴性杆菌的联合活性
Antimicrob Agents Chemother. 1974 Jul;6(1):84-92. doi: 10.1128/AAC.6.1.84.
2
In vitro comparison of four aminoglycoside antibiotics: sisomicin, gentamicin, tobramycin, and BB-K8.四种氨基糖苷类抗生素的体外比较：西索米星、庆大霉素、妥布霉素和BB-K8。
Antimicrob Agents Chemother. 1974 Jun;5(6):667-9. doi: 10.1128/AAC.5.6.667.
3
Amikacin (BB-K8) treatment of multiple-drug resistant Proteus infections.阿米卡星（BB-K8）治疗多重耐药变形杆菌感染。
Antimicrob Agents Chemother. 1974 May;5(5):435-8. doi: 10.1128/AAC.5.5.435.
4
Single-dose daily gentamicin therapy in urinary tract infection.单剂量每日庆大霉素治疗尿路感染。
Antimicrob Agents Chemother. 1974 Oct;6(4):465-70. doi: 10.1128/AAC.6.4.465.
5
In vitro activity, synergism, and testing parameters of amikacin, with comparisons to other aminoglycoside antibiotics.阿米卡星的体外活性、协同作用及测试参数，并与其他氨基糖苷类抗生素进行比较。
Antimicrob Agents Chemother. 1976 Mar;9(3):440-7. doi: 10.1128/AAC.9.3.440.
6
Penetration of amikacin into the aphakic eye.阿米卡星在无晶状体眼中的穿透情况。
Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1975 Aug 4;196(1):85-94. doi: 10.1007/BF00410030.
7
Tobramycin: maternal-fetal pharmacology.妥布霉素：母胎药理学
Antimicrob Agents Chemother. 1977 Apr;11(4):688-94. doi: 10.1128/AAC.11.4.688.
8
In vitro comparison of gentamicin, tobramycin, sisomicin, and netilmicin.庆大霉素、妥布霉素、西索米星和奈替米星的体外比较。
Antimicrob Agents Chemother. 1976 Oct;10(4):768-9. doi: 10.1128/AAC.10.4.768.
9
Tobramycin: a review of its antibacterial and pharmacokinetic properties and therapeutic use.妥布霉素：抗菌及药代动力学特性与治疗用途综述
Drugs. 1976;12(3):166-200. doi: 10.2165/00003495-197612030-00002.
10
Why monitor serum levels of gentamicin?为什么要监测庆大霉素的血清水平？
Clin Pharmacokinet. 1978 May-Jun;3(3):202-15. doi: 10.2165/00003088-197803030-00002.

本文引用的文献

1
In vitro evaluation of tobramycin, a new aminoglycoside antibiotic.新型氨基糖苷类抗生素妥布霉素的体外评价
Antimicrob Agents Chemother. 1972 May;1(5):381-4. doi: 10.1128/AAC.1.5.381.
2
BB-K 8, a new semisynthetic aminoglycoside antibiotic.
J Antibiot (Tokyo). 1972 Dec;25(12):695-708. doi: 10.7164/antibiotics.25.695.
3
Microbiological evaluation of BB-K 8, a new semisynthetic aminoglycoside.
J Antibiot (Tokyo). 1972 Dec;25(12):709-31. doi: 10.7164/antibiotics.25.709.